Concepedia

H. Ian Robins

HI

Statistics

Publications

142

Citations

9.4K

H-Index

52

Active since

1968

Affiliations

University of Wisconsin–Madison(Current)

The University of Texas MD Anderson Cancer Center

University of California, San Francisco

Memorial Sloan Kettering Cancer Center

University of Wisconsin Carbone Cancer Center

H. Ian Robins is an author at University of Wisconsin–Madison specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1968–2023

142

Publications

142

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 435 citations · Full text

, , +16

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn et al. · Clinical Cancer Research · 2006 · 426 citations

Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

Kathleen R. Lamborn, W.K. Alfred Yung, Susan M. Chang et al. · Neuro-Oncology · 2008 · 416 citations · Full text

, , +17

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy et al. · Investigational New Drugs · 2005 · 400 citations · Full text

, , +9

Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

Igor Vivanco, H. Ian Robins, Daniel Rohle et al. · Cancer Discovery · 2012 · 336 citations · Full text

Rows per page

1–5 of 142